axitinib
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
ax-i-ti-nib
![](.//images/locked-audio.png)
Trade Name(s)
- Inlyta
Ther. Class.
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Axitinib." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109650/all/axitinib.
Vallerand AHA, Sanoski CAC, . Axitinib. Davis's Drug Guide. F.A. Davis Company; 2025. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109650/all/axitinib. Accessed January 21, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Axitinib. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109650/all/axitinib
Vallerand AHA, Sanoski CAC, . Axitinib [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 21]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109650/all/axitinib.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - axitinib
ID - 109650
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109650/all/axitinib
PB - F.A. Davis Company
ET - 19
DB - Nursing Central
DP - Unbound Medicine
ER -